Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01596569 · ClinicalTrials.gov registry record · NA
Combined Transcranial Magnetic Stimulation and Cognitive Treatment in Blast Traumatic Brain Injury
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01596569 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 15 participants.
The verdict
NCT01596569, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
This study investigates the efficacy of a novel neurorehabilitation program combining noninvasive brain stimulation (transcranial magnetic stimulation or TMS) and cognitive therapy, on cognitive function and quality of life in individuals with blast-induced traumatic brain injury (bTBI).
Interventions
- DEVICE Repetitive Transcranial Magnetic Stimulation (rTMS)
- BEHAVIORAL Cognitive Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-05 |
| Est. Completion | 2017-11-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01596569
The ClinicalTrials.gov registry entry for NCT01596569 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Repetitive Transcranial Magnetic Stimulation (rTMS) is the first listed.
NCT01596569 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01596569 about?
NCT01596569 is a clinical study titled "Combined Transcranial Magnetic Stimulation and Cognitive Treatment in Blast Traumatic Brain Injury". This study investigates the efficacy of a novel neurorehabilitation program combining noninvasive brain stimulation (transcranial magnetic stimulation or TMS) and cognitive therapy, on cognitive function and quality of life in individuals with blast-induced traumatic brain injury (bTBI).
What is the current status of trial NCT01596569?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2012-05. Estimated completion is 2017-11-18.
What interventions are being tested in trial NCT01596569?
The interventions under investigation include: Repetitive Transcranial Magnetic Stimulation (rTMS) (DEVICE), Cognitive Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01596569?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.